Adults With Ulcerative Colitis clinical trials

Explore recruiting adults with ulcerative colitis clinical trials.

Recruiting adults with ulcerative colitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adults With Ulcerative Colitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Open-Label Extension Trial to Evaluate the Long-term Safety and Tolerability of Oral Zasocitinib (TAK-279) in Participants with Moderately to Severely Active Ulcerative Colitis and Moderately to Severely Active Crohn’s Disease

Czechia, Norway, Slovakia, Italy, Belgium, Netherlands +8 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants with Moderate-to-Severe Active Ulcerative Colitis.

Romania, Greece, Bulgaria, Italy, Croatia, Poland +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Multi-center, single-arm, phase II clinical trial evaluating efficacy and in-vivo homing of adoptively transferred autologous ex-vivo expanded regulatory T cells in adults with ulcerative colitis

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

J6Z-MC-IIBD - A Master Protocol for Phase 2, Randomized, Controlled Studies of Multiple Interventions for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease J6Z-MC-CD01 - A Phase 2, Multicenter, Randomized, Open-Label, Active-Controlled Study to Investigate LY4395089/Mirikizumab Co-administration Compared with Mirikizumab in Adults with Moderately to Severely Active Crohn’s Disease

Italy, Germany, Hungary, Poland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Adults With Ulcerative Colitis trials by city

Adults With Ulcerative Colitis in Toronto Adults With Ulcerative Colitis in Vancouver Adults With Ulcerative Colitis in Montreal Adults With Ulcerative Colitis in Calgary Adults With Ulcerative Colitis in Edmonton Adults With Ulcerative Colitis in Ottawa Adults With Ulcerative Colitis in Winnipeg Adults With Ulcerative Colitis in Quebec City Adults With Ulcerative Colitis in Hamilton Adults With Ulcerative Colitis in Kitchener Adults With Ulcerative Colitis in London Adults With Ulcerative Colitis in Halifax Adults With Ulcerative Colitis in New York Adults With Ulcerative Colitis in Los Angeles Adults With Ulcerative Colitis in Chicago Adults With Ulcerative Colitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease